As of 2024-09-14, the EV/EBITDA ratio of MEI Pharma Inc (MEIP) is 0.78. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MEIP's latest enterprise value is 17.81 mil USD. MEIP's TTM EBITDA according to its financial statements is 22.78 mil USD. Dividing these 2 quantities gives us the above MEIP EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 16.8x | 13.9x |
| Forward P/E multiples | 15.5x - 21.7x | 18.1x |
| Fair Price | 40.72 - 74.59 | 55.09 |
| Upside | 1244.0% - 2361.7% | 1718.1% |
| Date | EV/EBITDA |
| 2024-09-13 | 0.78 |
| 2024-09-12 | 0.79 |
| 2024-09-11 | 0.78 |
| 2024-09-10 | 0.80 |
| 2024-09-09 | 0.76 |
| 2024-09-06 | 0.80 |
| 2024-09-05 | 0.82 |
| 2024-09-04 | 0.80 |
| 2024-09-03 | 0.81 |
| 2024-08-30 | 0.80 |
| 2024-08-29 | 0.85 |
| 2024-08-28 | 0.81 |
| 2024-08-27 | 0.83 |
| 2024-08-26 | 0.83 |
| 2024-08-23 | 0.81 |
| 2024-08-22 | 0.79 |
| 2024-08-21 | 0.81 |
| 2024-08-20 | 0.81 |
| 2024-08-19 | 0.80 |
| 2024-08-16 | 0.82 |
| 2024-08-15 | 0.82 |
| 2024-08-14 | 0.89 |
| 2024-08-13 | 0.89 |
| 2024-08-12 | 0.90 |
| 2024-08-09 | 0.89 |
| 2024-08-08 | 0.89 |
| 2024-08-07 | 0.90 |
| 2024-08-06 | 0.88 |
| 2024-08-05 | 0.91 |
| 2024-08-02 | 0.88 |
| 2024-08-01 | 0.91 |
| 2024-07-31 | 0.98 |
| 2024-07-30 | 0.90 |
| 2024-07-29 | 0.93 |
| 2024-07-26 | 0.94 |
| 2024-07-25 | 0.91 |
| 2024-07-24 | 0.86 |
| 2024-07-23 | 0.96 |
| 2024-07-22 | 0.91 |
| 2024-07-19 | 0.73 |
| 2024-07-18 | 0.73 |
| 2024-07-17 | 0.74 |
| 2024-07-16 | 0.72 |
| 2024-07-15 | 0.73 |
| 2024-07-12 | 0.74 |
| 2024-07-11 | 0.72 |
| 2024-07-10 | 0.71 |
| 2024-07-09 | 0.72 |
| 2024-07-08 | 0.72 |
| 2024-07-05 | 0.71 |